You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-MET (MET) Antibodies

Full name:
anti-Met Proto-Oncogene Antibodies (MET)
On www.antibodies-online.com are 681 Met Proto-Oncogene (MET) Antibodies from 33 different suppliers available. Additionally we are shipping MET Kits (56) and MET Proteins (50) and many more products for this protein. A total of 813 MET products are currently listed.
Synonyms:
AI838057, AUTS9, c-met, HGF, Hgfr, Par4, RCCP2
list all antibodies Gene Name GeneID UniProt
MET 4233 P08581
MET 17295  
MET 24553 P97523

Show all species

Show all synonyms

Most Popular Reactivities for anti-MET (MET) Antibodies

Select your species and application

anti-Human MET Antibodies:

anti-Mouse (Murine) MET Antibodies:

anti-Rat (Rattus) MET Antibodies:

All available anti-MET Antibodies

Go to our pre-filtered search.

Top referenced anti-MET Antibodies

  1. Human Monoclonal MET Primary Antibody for FACS, IHC (p) - ABIN1688523 : Zagouri, Bago-Horvath, Rössler, Brandstetter, Bartsch, Papadimitriou, Dimitrakakis, Tsigginou, Papaspyrou, Giannos, Dimopoulos, Filipits: High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer. in British journal of cancer 2013 (PubMed)
    Show all 36 references for ABIN1688523

  2. Human Polyclonal MET Primary Antibody for WB - ABIN197478 : Fan, Ma, Gao, Yuan, Meng, Goldberg, Rosen: The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair. in Molecular and cellular biology 2001 (PubMed)
    Show all 5 references for ABIN197478

  3. Human Polyclonal MET Primary Antibody for EIA, IHC (p) - ABIN358164 : Wong, Roskelley, Pelech, Miller, Leung, Auersperg: Progressive changes in Met-dependent signaling in a human ovarian surface epithelial model of malignant transformation. in Experimental cell research 2004 (PubMed)
    Show all 5 references for ABIN358164

  4. Human Polyclonal MET Primary Antibody for EIA, WB - ABIN358165 : Higuchi, Orita, Katsuya, Yamasaki, Akiyama, Li, Yamamoto, Saito, Nakamura: MUC20 suppresses the hepatocyte growth factor-induced Grb2-Ras pathway by binding to a multifunctional docking site of met. in Molecular and cellular biology 2004 (PubMed)
    Show all 5 references for ABIN358165

  5. Human Polyclonal MET Primary Antibody for EIA, WB - ABIN401383 : Longati, Comoglio, Bardelli: Receptor tyrosine kinases as therapeutic targets: the model of the MET oncogene. in Current drug targets 2001 (PubMed)
    Show all 3 references for ABIN401383

  6. Human Polyclonal MET Primary Antibody for IF (p), IHC (p) - ABIN671661 : Gao, Bing, Li, Yang, Li, Chen: Study of critical role of c-Met and its inhibitor SU11274 in colorectal carcinoma. in Medical oncology (Northwood, London, England) 2013 (PubMed)
    Show all 3 references for ABIN671661

  7. Human Polyclonal MET Primary Antibody for IHC (p), WB - ABIN389595 : Guo, Prins, Dang, Kuga, Iwanami, Soto, Lin, Huang, Akhavan, Hock, Zhu, Kofman, Bensinger, Yong, Vinters, Horvath, Watson, Kuhn, Robins, Mehta, Wen, DeAngelis, Prados, Mellinghoff, Cloughesy, Mischel: EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy. in Science signaling 2009 (PubMed)
    Show all 2 references for ABIN389595

  8. Human Polyclonal MET Primary Antibody for IF, ELISA - ABIN1533596 : Hillier, Fulton, Fulton, Graves, Pepin, Wagner-McPherson, Layman, Maas, Jaeger, Walker, Wylie, Sekhon, Becker, OLaughlin, Schaller, Fewell, Delehaunty, Miner, Nash, Cordes, Du, Sun, Edwards et al.: The DNA sequence of human chromosome 7. ... in Nature 2003 (PubMed)
    Show all 2 references for ABIN1533596

  9. Human Polyclonal MET Primary Antibody for DB - ABIN389596 : Xu, Xia, Baker, Zhou, Cha, Voorhees, Fisher: Receptor-type protein tyrosine phosphatase beta (RPTP-beta) directly dephosphorylates and regulates hepatocyte growth factor receptor (HGFR/Met) function. in The Journal of biological chemistry 2011 (PubMed)

More Antibodies against MET Interaction Partners

Human Met Proto-Oncogene (MET) interaction partners

  1. both EGCG and miR-1 mimic inhibited c-MET expression, and combination treatment with EGCG and c-MET inhibitor (crizotinib) had enhanced inhibitory effects on the growth of MG-63 and U-2OS cells. Taken together, these results suggest that EGCG has an anticancer effect on OS cells, at least partially, through regulating miR-1/c-MET interaction.

  2. This study showed that c-Met expression was not associated with survival outcomes in extrahepatic bile duct cancer patients undergoing curative resection followed by adjuvant chemoradiotherapy

  3. Our data indicate that over-expression of MET and KIT in primary adult soft tissue sarcomas samples and its derived cell lines is associated with miR (show MLXIP Antibodies)-152 down-regulation

  4. complete loss of one or both MET and RON (show MST1R Antibodies), as well as their overexpression, is a poor prognostic factor in patients with extrahepatic cholangiocarcinoma, probably due to the high rate of lymph-node metastasis

  5. c-MET-positive advanced gastric cancer patients had a poorer prognosis than c-MET-negative patients.

  6. HDAC5 promotes cellular proliferation through the upregulation of cMet, and may provide a novel therapeutic target for the treatment of patients with Wilms' tumor.

  7. Using cytokine array analysis, we were able to demonstrate that GSC1 cell growth is mediated through hepatocyte growth factor (HGF (show HGF Antibodies))/c-MET signaling pathway which is activated exclusively by HGF (show HGF Antibodies) secreted from gastric carcinoma mesenchymal stem cells.

  8. high expression of c-Met might predict TMZ chemotherapy resistance both for patients and in vitro. Based on these results, c-Met may be a useful biomarker for identifying patients who should be candidates for more aggressive therapies such as c-Met targeted medicine.

  9. Notably, other mutations including MET, APC (show APC Antibodies), CDH1 (show CDH1 Antibodies), and FBXW7 (show FBXW7 Antibodies) were also identified in Taiwanese oral squamous cell carcinoma patients.

  10. Results detected significantly higher levels of MET in thyroid carcinoma (TC) and was found as a Mir (show MLXIP Antibodies)-3666 target through its 3'UTR (show UTS2R Antibodies) binding to promote TC cell proliferation.

Mouse (Murine) Met Proto-Oncogene (MET) interaction partners

  1. study demonstrates that co-activation of AKT (show AKT1 Antibodies) and c-Met induces hepatocellular carcinoma development that depends on the mTORC1/FASN (show FASN Antibodies) pathway.

  2. Molecular and functional studies revealed that ectopic Met expression in limb mesenchyme does not alter HGF (show HGF Antibodies) expression patterns and levels, but impairs HGF (show HGF Antibodies) bioavailability

  3. miR-206 suppressed c-Met expression in gastric cancer and could function as a potent tumor suppressor in c-Met overexpressing tumors.

  4. Meg3 overexpression in insulinoma cells down-regulated the expression of the protooncogene c-met.

  5. our results support the concept of the acrosome as a lysosome-related organelle and provide evidence for the identification of MET as a tyrosine kinase receptor (show KDR Antibodies) that may play a role in fertilization.

  6. We show that a subset of adult calcitonin gene-related peptide (CGRP (show CALCA Antibodies))-expressing myenteric neurons produce MET, the receptor for hepatocyte growth factor (show HGF Antibodies).

  7. HGF and c-met inhibition by means of a novel monoclonal neutralizing antibody inhibits tumor growth in prostate cancer cells and in mouse xenografts.

  8. facilitates T cell recruitment to the heart via CCR5 (show CCR5 Antibodies) receptor by inducing autocrine CCR5 (show CCR5 Antibodies) ligand release

  9. C-Met pathway is suggested to contribute to the lymphomagenesis in the MALT lymphoma after H. heilmannii infection.

  10. c-Met targeting enhances the effect of irradiation and chemical agents against malignant colon cells harboring a KRAS mutation.

Cow (Bovine) Met Proto-Oncogene (MET) interaction partners

  1. possible cooperative role of the EGF (show EGF Antibodies) and HGF (show HGF Antibodies) pathways and indicate that cross-talk between their respective receptors may modulate mammary gland development in the cow

MET Antigen Profile

Antigen Summary

The proto-oncogene MET product is the hepatocyte growth factor receptor and encodes tyrosine-kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. Various mutations in the MET gene are associated with papillary renal carcinoma. Two transcript variants encoding different isoforms have been found for this gene.

Alternative names and synonyms associated with MET

  • met proto-oncogene (MET) antibody
  • met proto-oncogene (Met) antibody
  • met proto-oncogene (hepatocyte growth factor receptor) (MET) antibody
  • AI838057 antibody
  • AUTS9 antibody
  • c-met antibody
  • HGF antibody
  • Hgfr antibody
  • Par4 antibody
  • RCCP2 antibody

Protein level used designations for MET

HGF receptor , HGF/SF receptor , SF receptor , hepatocyte growth factor receptor , met proto-oncogene tyrosine kinase , proto-oncogene c-Met , scatter factor receptor , tyrosine-protein kinase Met , c-Met , HGF receptor c-Met

GENE ID SPECIES
4233 Homo sapiens
17295 Mus musculus
24553 Rattus norvegicus
403438 Canis lupus familiaris
280855 Bos taurus
654328 Sus scrofa
100126565 Oryctolagus cuniculus
Selected quality suppliers for anti-MET (MET) Antibodies
Did you look for something else?